HeartBeam Inc. (NASDAQ: BEAT), a medical-technology company developing next-generation cardiac diagnostics via its patented 12-Lead ECG synthesis software, has announced a strategic collaboration with HeartNexus (https://ibn.fm/yyz1i). The partnership will expand access to cardiologist-level ECG insights for arrhythmia assessment anytime, anywhere.
Cardiovascular disease remains the leading cause of mortality worldwide, responsible for an estimated 17.9 million deaths annually according to the World Health Organization (https://ibn.fm/oQxTL). ECGs are the most common cardiac test, yet standard ECG testing often requires in-clinic visits, specialized equipment, and scheduling delays. The HeartBeam System addresses these limitations by enabling a patient to capture a 30-second ECG recording with its credit-card-sized, cable-free device, regardless of where they are.
The HeartBeam-HeartNexus collaboration makes board-certified cardiologists available 24/7 to interpret the results for arrhythmia assessment and provide expert feedback directly to the patient or to a coordinating clinician. This integration aims to bridge the gap between remote ECG capture and timely, expert analysis, potentially reducing the time to diagnosis and treatment for patients with suspected arrhythmias.
HeartBeam's technology is designed for use in both clinical settings and at home. The HeartBeam System is a portable non-invasive recorder intended to record, store, and transfer a patient’s 3-Lead (in three-directions) electrocardiogram acquired from 5 electrodes. The device does not conduct cardiac analysis and can be used with an ECG Viewer software system for manual interpretation of non-life-threatening arrhythmias by a physician or healthcare professional. For full safety information, see the full Instructions for Use or Clinician Portal Manual.
This partnership underscores the growing trend toward remote patient monitoring and telehealth solutions, particularly in cardiology. By combining HeartBeam's portable ECG technology with HeartNexus's network of cardiologists, the collaboration seeks to provide continuous access to expert cardiac care, potentially improving outcomes for patients with cardiovascular conditions.
Investors and stakeholders can find the latest news and updates relating to BEAT in the company’s newsroom at https://ibn.fm/BEAT.
